DeepMed Research

UKC Ljubljana

🇸🇮Slovenia

Country: 🇸🇮Slovenia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hydrogen Sulfide as Prognostic Factor

Completed

Conditions: Mortality
Shock

First Posted Date: 2010-03-17

Last Posted Date: 2014-12-05

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 50

Registration Number: NCT01088490

Locations: 🇸🇮
University Medical Center, Ljubljana, Slovenia

Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age

Conditions: Bronchiolitis
Convulsion, Febrile
Gastroenteritis

First Posted Date: 2009-10-01

Last Posted Date: 2010-07-07

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 1260

Registration Number: NCT00987519

Locations: 🇸🇮
Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
🇸🇮
Department of Pediatric Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
🇸🇮
Institute of Microbiology and Immunology, Ljubljana, Slovenia

Selective Vagus Nerve Stimulation in Human

Not Applicable

Completed

Conditions: Arterial Hypertension
Ischemic Heart Disease

Interventions: Device: selective vagus nerve stimulation

First Posted Date: 2009-09-24

Last Posted Date: 2016-01-07

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 4

Registration Number: NCT00983632

Locations: 🇸🇮
University medical center, Ljubljana, Slovenija, Slovenia

Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis

Not Applicable

Conditions: Suspected Early Lyme Neuroborreliosis

Interventions: Drug: ceftriaxone
Drug: doxycycline

First Posted Date: 2009-07-20

Last Posted Date: 2009-07-20

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 200

Registration Number: NCT00942006

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Postencephalitic Symptoms After Tick Borne Encephalitis

Conditions: Central European Encephalitis

First Posted Date: 2009-07-17

Last Posted Date: 2009-07-17

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 200

Registration Number: NCT00941590

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Study on Early Lyme Neuroborreliosis

Not Applicable

Conditions: Nervous System Lyme Borreliosis

Interventions: Drug: ceftriaxone

First Posted Date: 2009-06-01

Last Posted Date: 2018-10-16

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 50

Registration Number: NCT00910533

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Duration of Antibiotic Treatment of Erythema Migrans

Not Applicable

Completed

Conditions: Erythema Chronicum Migrans

Interventions: Drug: placebo
Drug: doxycycline

First Posted Date: 2009-06-01

Last Posted Date: 2017-06-02

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 306

Registration Number: NCT00910715

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Enteral Versus Parenteral Glutamine Supplement

Phase 4

Terminated

Conditions: Critically Ill

Interventions: Dietary Supplement: enteral glutamine
Dietary Supplement: parenteral glutamine

First Posted Date: 2009-04-03

Last Posted Date: 2014-01-16

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 90

Registration Number: NCT00875797

Locations: 🇸🇮
General Hospital Slovenj Gradec, Slovenj Gradec, Slovenia

International Navigator Hypoglycaemia Study

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1
Hypoglycemia

Interventions: Device: Navigator continuous glucose monitor (Freestyle Navigator®)

First Posted Date: 2009-02-13

Last Posted Date: 2010-02-05

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 122

Registration Number: NCT00843609

Locations: 🇮🇱
Schneider Children's Medical Center of Israel, Petah Tikva, Israel
🇸🇮
UMC Ljubljana - University Children's Hospital, Ljubljana, Slovenia
🇸🇪
Karolinska Institutet, Stockholm, Sweden

Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

Phase 2

Completed

Conditions: Dilated Cardiomyopathy

Interventions: Biological: CD34+ autologous stem cell transplantation
Drug: Bone Marrow Stimulation
Biological: SC therapy

First Posted Date: 2008-03-05

Last Posted Date: 2015-05-12

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 110

Registration Number: NCT00629018

Locations: 🇸🇮
Ljubljana University Medical Center, Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy